Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide-bolus vs Glargine-bolus in T2D (LiraGooD)
NCT03087032Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Jan 2019
- Primary completion
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by First Affiliated Hospital of Xiamen University. Started Jan 2019; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03087032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087032.